Patients were offered escalating doses of semaglutide (0.25, 0.5, 1.0, 1.25, 1.5 and 2.0 mg depending on tolerance and affordability) and dosing was assessed at 3 monthly intervals
Our team formulates and ships BPC-157 as a lyophilized powder to maintain full stability
Results vary based on consistency, dosage, and lifestyle factors, so lack of progress doesnt always mean the medication has failed
This is an emerging area of research and not yet clinically actionable, but it explains why two people on the same dose can have noticeably different responses in the first 4 to 8 weeks
101 The cAMP/ PKA pathway is also involved in the protection of astrocytes from AGE-induced inflammatory response
2 UMAP of neuronal populations split by species